Decision to list medical devices in the interventional radiology category supplied by Merit Medical Ltd
We are pleased to announce the approval of a listing agreement for medical devices with Merit Medical Ltd.
Proposal to list medical devices supplied by Bunzl Outsourcing Services NZ Limited and B. Braun New Zealand Pty Limited
PHARMAC is seeking feedback on a proposal to list a range of continence products and urology products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2019, through listing agreements with Bunzl Outsourcing Services NZ Limited and B. Braun New Zealand Pty Limited.
Closes: 4pm Wednesday, 29 May 2019.
OIA Response: Antiepileptic medicines data
16 April 2019
Request dated 19 March 2019 under the Official Information Act 1982 (OIA) relating to females on antiepileptic medicines.
Decision to list a new brand of labetalol
PHARMAC has made a decision to fund a new brand of labetalol tablets (Presolol). This is to replace the currently funded brand of labetalol tablets (Hybloc), which is being discontinued by its supplier.
Proposal to list a range of orthopaedic implants and associated products supplied by Medartis New Zealand Ltd and Pioneer Medical Limited
PHARMAC is seeking feedback on a proposal to list a range of orthopaedic implants and associated products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2019, through provisional agreements with Medartis New Zealand Ltd and Pioneer Medical Limited.
Closes: 4pm Tuesday, 28 May 2019.
Decision to list medical devices in the interventional radiology category supplied by Obex Medical Ltd
We are pleased to announce the approval of a listing agreement for medical devices with Obex Medical Ltd.
Decision to list urology, ostomy and continence products
We are pleased to announce the approval of non-exclusive listing agreements with EBOS Group Limited, Ainscorp Pty Ltd and New Zealand Medical & Scientific Limited for the supply of urology, ostomy and continence products to DHBs.
OIA Response: Erlotinib and other medicines data
Request for information dated 4 February 2019 on erlotinib, obinutuzumab, pertuzumab, pirfenidone, rutixmab, trastuzumab, melanoma, multiple sclerosis and gefitinib.
RFP - supply of the levonorgestrel intrauterine system
PHARMAC invites proposals for the supply of the levonorgestrel intrauterine system in New Zealand.
All proposals must be submitted to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 4pm NZT Thursday 30 May 2019 - RFx ID 21000578.
If you have any questions about this RFP, please post these on the Government Electronic Tenders Service (www.gets.govt.nz).
Answers to questions will be provided through the Government Electronic Tenders Service (GETS). PHARMAC will also post any addenda through GETS. We encourage interested organisations to register with GETS and subscribe to this RFP to be kept up to date.
Decision to list needles and syringes products supplied by Becton Dickinson Limited and Terumo Australia Pty Limited
We are pleased to announce the approval of two non-exclusive listing agreements with Becton Dickinson Limited and Terumo Australia Pty Limited for the supply of needle and syringe products to DHBs.
Proposal to widen access to etanercept and award sole supply
We are proposing to make changes to the funding of etanercept, a biologic medicine used to reduce chronic inflammation and treat immune-mediated conditions such as arthritis and psoriasis, from 1 July 2019.
Closes: 5pm on Friday, 17 May 2019.
OIA response: Sleeping medicines data
Request dated 04 March 2019 for information relating to sleeping pill medications.
Decision to amend the distribution and access criteria for dasatinib (Sprycel)
PHARMAC has a made a decision to change the distribution arrangements and access criteria for the funding of dasatinib (Sprycel) tablets for chronic myeloid leukaemia (CML) and acute lymphoid leukaemia (ALL) from 1 June 2019.
Decision to list continence products supplied by Downs Distributors Limited
We are pleased to announce the approval of a non-exclusive listing agreement with Downs Distributors Limited for the supply of continence products to DHBs.
Proposal to decline inactive applications
To help make our decision-making process clearer, we are seeking feedback on a proposal for PHARMAC to make decisions to decline funding applications as detailed below.
Closes: 5pm Tuesday, 21 May 2019.
April 2019 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2018/19 Invitation to Tender, dated 1 November 2018.
PHARMAC fully funding innovative improvements in haemophilia treatment
PHARMAC has today provided haemophilia patients fully funded access to new innovative treatment options which will make a major difference to their lives, PHARMAC Director of Operations Lisa Williams says.
PHARMAC proposes to give more clarity about funding decisions
An overhaul of PHARMAC’s decision-making process will give better insight into what medicines are - and are not - being actively considered for funding, Chief Executive, Sarah Fitt says.
Proposal to list patient warming and cooling products supplied by Draeger New Zealand Limited
PHARMAC is seeking feedback on a proposal to list a range of patient warming and cooling products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2019, through a non-exclusive provisional agreement with Draeger New Zealand Limited.
Closes: 4pm, Friday 17 May 2019.
Proposal to list surgical suction, chest and wound drainage products supplied by Culpan Distributors Limited
PHARMAC is seeking feedback on a proposal to list a range of surgical suction, chest and wound drainage products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2019 through a provisional Agreement with Culpan Distributors Limited.
Closes: 4pm Friday, 17 May 2019.
Newsletters
Device Advice: Your update on PHARMAC’s Hospital Medical Devices programme.
Te Whaioranga ePānui: A PHARMAC newsletter for people with an interest in Māori health.
